Germany· DE-A57-916e57dcd367d072
Suvexx
A medicinal product containing naproxen sodium, sumatriptan succinate, registered in Germany by Orion Corporation.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Naproxen Sodium, Sumatriptan Succinate
- Manufacturer
- Orion Corporation
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Naproxen sodium, sumatriptan succinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSumatriptan and Naproxen SodiumNorthStar RxLLC
- CzechiaFRIMIG DUOOrion Corporation, Espoo
- FinlandNomigrinOrion Corporation
- FranceNOMANESIT 85 mg/500 mg comprimé pelliculéORION CORPORATION
- CanadaSUVEXXARALEZ PHARMACEUTICALS CANADA INC
- IrelandMigsun 85 mg/500 mg film-coated tabletsOrion Corporation
- NetherlandsSuvexx 85 mg/500 mg filmomhulde tablettenOrion Corporation
- PolandFrimig DuoOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Sumanet
- Belgium · Migsun
- Czechia · Frimig Duo
- Denmark · Nomigrin
- Estonia · Migsun
- Spain · Suvexx
- Finland · Nomigrin
- France · Nomanesit
- United Kingdom (Northern Ireland) · Suvexx
- Greece · Suvexx
- Hungary · Nomigrin
- Ireland · Migsun
- Italy · Sumanet
- Lithuania · Migsun
- Latvia · Migsun
- Netherlands · Suvexx
- Norway · Nomigrin
- Poland · Frimig Duo
- Portugal · Suvexx
- Sweden · Nomigrin
- Slovakia · Frimig Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d91db156-8224-4b09-8eb3-bae824309c8b GET /v1/drugs/d91db156-8224-4b09-8eb3-bae824309c8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Naproxen Sodium, Sumatriptan Succinate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about naproxen sodium, sumatriptan succinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.